XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Operating Segments (Tables)
 9 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Operating Results For The Company's Reportable Segments Operating results for the Company’s reportable segments for each period presented in the consolidated statements of income and comprehensive income were as follows.
Three Months Ended December 31,Nine Months Ended December 31,
(in thousands of dollars)2024202320242023
SALES AND OTHER OPERATING REVENUES
   Tobacco Operations$853,884 $743,933 $1,996,051 $1,742,494 
   Ingredients Operations83,309 77,574 248,954 235,219 
Consolidated sales and other operating revenues$937,193 $821,507 $2,245,005 $1,977,713 
OPERATING INCOME (LOSS)
   Tobacco Operations$102,566 $87,605 $194,354 $148,875 
   Ingredients Operations3,659 2,167 7,903 4,964 
Segment operating income106,225 89,772 202,257 153,839 
Deduct: Equity in pretax (earnings) loss of unconsolidated affiliates (1)
(2,149)(1,384)(1,647)3,495 
              Restructuring and impairment costs (2)
— (924)(10,573)(3,523)
Consolidated operating income$104,076 $87,464 $190,037 $153,811 

(1)Equity in pretax earnings (loss) of unconsolidated affiliates is included in segment operating income (Tobacco Operations), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.
(2)Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income. See Note 2 for additional information.